Project Grant R00AR079554

Award Date 6/21/24
Completion Date 5/31/27
Dollars Obligated $249K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
This Project Grant award, valued at $242,310.00 and funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand how the intestinal microbiome interacts with the immune system during early life development. The primary objective is to investigate the mechanisms by which specific commensal bacteria are trafficked from the intestine to the thymus, where they stimulate the...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $126,174.00 to support research aimed at investigating the local immune response and granulopoiesis (production of neutrophils) in human skin during bacterial infections. The primary objectives of this 2.5-year project are to: 1) Demonstrate the role of the SDF-1/CXCR4 signaling axis in attracting and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $769,366 to fund research aimed at deciphering the development and maintenance of protective CD4+ resident memory T cells (DTRM) in the skin. The overarching goal is to leverage this understanding to optimize DTRM cell-mediated immunity for use in vaccines against vector-borne diseases, particularly leishmaniasis. Key...
This Project Grant award, titled "Identifying Inter-Kingdom Microbial Determinants of Altered Immunity in HIV Exposed Infants", is funded by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865). The $498,000 award will support a longitudinal study to investigate how the enteric virome and bacterial microbiota influence immune responses to vaccination in infants born to HIV-infected mothers....
This $262,170 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop a novel mucosal vaccine strategy that leverages the immune response to commensal skin microbiota. The key goals are to: 1) uncover the B cell response to skin commensal microbes, 2) generate new technologies to probe commensal-specific immunity at the skin barrier, and 3) engineer skin commensal...
This federal Project Grant award of $438,608 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to determine the mechanism by which host genetics directly influence the intestinal population of Lactobacillus murinus, a prominent gut microbiome member. The project will utilize a murine model to eliminate environmental factors and study the role of host genetics in shaping this...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is funding research to investigate the role of gene regulatory networks in neonatal nutrition and immunity. The $309,496 award will support a 2-year research project led by Duke University to define the gene regulatory networks controlled by the transcription factors MAFB, CMAF, and BLIMP1, and how they...
This Project Grant award of $508,500 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to elucidate the relationships between breastfeeding, early-life microbiome development, and childhood respiratory health outcomes. The study will leverage two established birth cohorts to investigate microbial colonization patterns across nasal/airway and gut niches, identifying genetic...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to investigate the association between early life immune responses and intergenerational cardiometabolic outcomes. The $245,625 award, with a performance period from September 2024 to August 2026, will leverage the resources of the Boston Birth Cohort to explore how maternal infection, immune responses,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, provides $101,577 to Michigan State University to investigate the mechanisms by which early life adversity (ELA) alters mast cell (MC) programming and inflammatory phenotype. The research aims to define how ELA modulates MC cholesterol metabolism, granulogenesis, and proinflammatory activity, which can heighten susceptibility...

ELUCIDATING MICROBIAL AND HOST MECHANISMS SUPPORTING EARLY LIFE IMMUNE IMPRINTING BY SKIN MONOCYTES - PROJECT SUMMARY/ABSTRACT: EARLY LIFE INTERACTIONS BETWEEN COMMENSAL MICROBES AND THE DEVELOPING IMMUNE SYSTEM HAVE FORMATIVE EFFECTS ON HUMAN HEALTH AND SUSCEPTIBILITY TO CHRONIC INFLAMMATORY DISEASE. PREVIOUS STUDIES FROM THE HOST LAB AND OTHER GROUPS HAVE DEMONSTRATED THAT OUR MICROBIAL SYMBIONTS CAN TUNE SKIN-RESIDENT T CELL FUNCTION, ESPECIALLY DURING THE NEONATAL WINDOW. HOWEVER, COMPARATIVELY LITTLE IS KNOWN ABOUT HOW COMMENSALS INFLUENCE CUTANEOUS MYELOID IMMUNITY IN EARLY LIFE. DR. DHARIWALA HAS FOUND THAT COMMENSAL MICROBES INFLUENCE THE COMPOSITION AND FUNCTION OF THE MYELOID COMPARTMENT IN NEONATAL SKIN. SPECIFICALLY, COMMENSAL MICROBES DRIVE THE ACCUMULATION OF A POPULATION OF LY6CHIMHC-IILO INFLAMMATORY MONOCYTES IN NEONATAL SKIN. THESE CELLS HAVE TRADITIONALLY BEEN STUDIED AS PRIMARY MEDIATORS OF INFLAMMATION IN RESPONSE TO INFECTION OR FOR THEIR ABILITY TO FILL VACANT TISSUE MYELOID NICHES. HOWEVER, DR. DHARIWALA'S PRELIMINARY STUDIES DEMONSTRATE A PREVIOUSLY UNEXPLORED REGULATORY IMMUNE IMPRINTING ROLE FOR NEONATAL SKIN MONOCYTES. TO DISSECT THE MOLECULAR MECHANISMS THAT UNDERPIN THIS PHENOMENON, WE WILL EMPLOY A COMBINATION OF TRANSGENIC MOUSE MODELS, HIGH THROUGHPUT ASSAYS LIKE MASS CYTOMETRY AND SINGLE CELL RNA SEQUENCING ALONG WITH NOVEL EX VIVO TRANSLATIONAL TOOLS. STUDIES PROPOSED IN THIS APPLICATION WILL (AIM 1) DISSECT THE MECHANISM(S) BY WHICH COMMENSAL MICROBES INFLUENCE MONOCYTE RECRUITMENT AND FUNCTION IN NEONATAL SKIN, (AIM 2) ELUCIDATE THE MECHANISM(S) BY WHICH NEONATAL MONOCYTES CONTRIBUTE TO SKIN IMMUNE HOMEOSTASIS AND (AIM 3) FUNCTIONALLY ELUCIDATE THE ROLE OF NEONATAL MONOCYTES IN HUMAN SKIN. RESULTS FROM THIS CROSS-DISCIPLINARY APPROACH WILL BENEFIT OUR UNDERSTANDING OF EARLY IMMUNE DEVELOPMENT AND LAY THE GROUNDWORK FOR NEXT GENERATION THERAPIES FOR CHRONIC INFLAMMATORY DISEASES. THE PROPOSED RESEARCH AND TRAINING PLAN WILL BUILD ON DR. DHARIWALA'S STRENGTHS IN THE FIELDS OF MICROBIOLOGY, IMMUNOLOGY AND TRANSLATIONAL SCIENCE. LEVERAGING TOOLS HE HAS ESTABLISHED IN THE HOST LAB, SUCH AS MASS CYTOMETRY, EX VIVO FUNCTIONAL ASSAYS IN HUMAN SKIN AND MANIPULATION OF SKIN-RESIDENT MYELOID CELL POPULATIONS IN MURINE MODELS, ALONG WITH STUDIES LIKE METABOLOMICS PROPOSED IN THIS APPLICATION WILL NOT ONLY ELEVATE THE PROJECT BUT ALSO ADVANCE HIS TRAINING. HIS SCIENTIFIC AND CAREER PROGRESS WILL BE WELL SUPPORTED BY A STRONG MENTORSHIP TEAM INCLUDING DRS. TIFFANY SCHARSCHMIDT, CLIFFORD LOWELL, MICHAEL ROSENBLUM AND PETER TURNBAUGH. ADDITIONALLY, THROUGH PRESENTATIONS AT LOCAL AND INTERNATIONAL CONFERENCES ALONG WITH FORMAL AND INFORMAL TRAINING AT UCSF DR. DHARIWALA WILL ADVANCE HIS TRANSITION TO INDEPENDENCE. PROMISING PRELIMINARY DATA, A STRONG TRAINING PLAN AND AN EXCELLENT TRAINING ENVIRONMENT WILL ALLOW DR. DHARIWALA TO CARVE OUT A NICHE FOR HIMSELF AND ESTABLISH AN INDEPENDENT RESEARCH PROGRAM STUDYING THE INFLUENCE OF COMMENSAL MICROBES ON MYELOID IMMUNE DEVELOPMENT IN NEONATAL BARRIER TISSUES.

Posted 6/21/24, 12:00 AM